ArticleACS medicinal chemistry letters2020

Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition.

Zhenhua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.